Microcrystalline Cellulose Market Share

North America Market Analysis

North America microcrystalline cellulose market is to maintain a 35% revenue share by 2037, driven by growth from strong demand from the pharmaceutical, food and beverage, and cosmetics industries, incentivized by the FDA's regulations restricting permissible excipients to high purity excipients and sustainable biomaterials and driven by new biopolymer technologies and government-sponsored green chemistry initiatives.

 The U.S. microcrystalline cellulose market is projected to reach $1.3 billion by 2037, at a 6.6% CAGR from demand for pharmaceuticals, food, and beverage additives. In addition, under recently initiated government programs, including the EPA's $51 million Green Chemistry Program (2023), sustainable MCC was adopted along the supply chain, with much less waste generated by MCC production (up to 26% lower production waste). Further support for new bio-based MCC is developed through federal agency initiatives like the U.S. Department of Energy's $751 million clean energy advanced manufacturing grant program (2023) that ultimately fulfills the U.S. goal of 31% biobased chemicals by 2035.

In Canada, the microcrystalline cellulose (MCC) market is projected to total $181 million by 2037, up 5.9% from 2022, with sustained demand from expanding demand for pharmaceuticals and nutraceuticals. The food & beverage sector contributes to 31% of the MCC demand and is driven by the clean-label trend and the supported and explicit regulations by Health Canada related to permitted additives. Government investments, like Canada's $1.5 billion Clean Energy Fund (2023), are promoting sustainable high-purity MCC from bio-sources, accounting for 21% lower CO2 outputs from the pilot/commercial production.

Asia Pacific Market Analysis

 The APAC microcrystalline cellulose market will have a revenue share of 28% globally in 2037, with growth in pharmaceuticals, food, and cosmetics. The pharmaceuticals sector makes up 50% of MCC usage, aided by China's $140 billion drug market (2023, CPCIF). 

The microcrystalline cellulose (MCC) market has a $2 billion output projection for China, and is anticipated to grow at an 8.2% CAGR until 2037 on the back of increases in food additives and pharmaceutical usage. This represents the potential for a 20% carbon emissions reduction.  ChemChina, for example, allocated $500 million in 2023 to convert some of its outputs in the sustainable MCC sector to cater to binders in lithium-ion batteries.

The microcrystalline cellulose market in India is expected to expand at a CAGR of 9.5% to $800 million by 2037, as a result of its $65 billion pharmaceutical industry (2023, DST). The Government of India also initiated plans that resulted in a $200 million grant, i.e., the Department of Science and Technology (DST) - biotechnology department, which ended new start-up positioning, continues to grant and support further R&D in MCC, which reduced MCC import dependence by 15%.